Program Development
Developing Novel Treatments Through Microbiome Testing
Creating Microbial-Based Products To Treat Mental Illness
Taylored Biotherapeutics is a platform company researching and developing novel treatments for a variety of mental illnesses. Our research has found a significant association between the health of the brain and the gut microbiome, allowing us to tailor treatments for different illnesses.
Taylored Biotherapeutics is a neuroscience led company informed by some of the only clinical fecal transplant studies for mental illness in the world. This has supported a precision medicine approach to developing microbial therapeutics.
Current Pipeline
Product Name | Safety and Efficacy Testing | Bacterial Tracing Characterization | Prototype Development | Phase I |
---|---|---|---|---|
TBIBipDep-01 | Completed | Completed | Completed | Protocol Development |
TBIDepression-02 | Ongoing. Anticipated end date: Q3 2023 |
Planned | Planned | Protocol Development |
TBIOCD-03 | Ongoing. Anticipated end date: Q2 2023 |
Planned | Planned | Protocol Development |